6533b855fe1ef96bd12b06fb

RESEARCH PRODUCT

Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5

Eva-maria Krämer-albersRakshit DardawalMartin MeschkatTing SunMaria A. Eichel-vogelSophie B SiemsTorben RuhwedelOlaf JahnOlaf JahnChristina MüllerHauke B. WernerSusann BoretiusTor R. MemhaveWiebke MöbiusKlaus-armin NaveTobias J. BuschamAnna M. SteyerNicola Strenzke

subject

0303 health sciencesMutationBiologymedicine.disease_causeCell biology03 medical and health sciencesMyelin0302 clinical medicinemedicine.anatomical_structurenervous systemUltrastructuremedicine030217 neurology & neurosurgeryBiogenesis030304 developmental biology

description

AbstractOligodendrocytes facilitate rapid impulse propagation along the axons they myelinate and support their long-term integrity. However, the functional relevance of many myelin proteins has remained unknown. Here we find that expression of the tetraspan-transmembrane protein CMTM5 (Chemokine-like factor-like MARVEL-transmembrane domain containing protein 5) is highly enriched in oligodendrocytes and CNS myelin. Genetic disruption of the Cmtm5-gene in oligodendrocytes of mice does not impair the development or ultrastructure of CNS myelin. However, oligodendroglial Cmtm5-deficiency causes an early-onset progressive axonopathy, which we also observe in global and in tamoxifen-induced oligodendroglial Cmtm5-mutants. Presence of the Wlds mutation ameliorates the axonopathy, implying a Wallerian degeneration-like pathomechanism. These results indicate that CMTM5 is involved in the function of oligodendrocytes to maintain axonal integrity rather than myelin biogenesis.

https://doi.org/10.1101/2021.11.22.469514